Esnouf et al., 1968 - Google Patents
Enzymology and the blood clotting mechanismEsnouf et al., 1968
- Document ID
- 9767336906674592016
- Author
- Esnouf M
- Macfarlane R
- Publication year
- Publication venue
- Adv Enzymol Relat Areas Mol Biol
External Links
Snippet
The first suggestion that blood coagulation involved enzyme action seems to have been made by Alexander Schmidt (234) when he used the term" fibrin ferment" to describe the coagulant material separated by alcohol precipitation from serum. Morawitz (186) went …
- 230000023555 blood coagulation 0 title abstract description 48
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Esnouf et al. | Enzymology and the blood clotting mechanism | |
Esmon et al. | Protein C activation | |
Niewiarowski et al. | Studies on the adsorption and activation of the Hageman factor (factor XII) by collagen and elastin | |
Esmon | The regulation of natural anticoagulant pathways | |
Walker | Protein S and the regulation of activated protein C | |
Walker | Regulation of bovine activated protein C by protein S: the role of the cofactor protein in species specificity | |
Civello et al. | Substrate specificity of a hemorrhagic proteinase from timber rattlesnake venom | |
Naski et al. | Characterization of the kinetic pathway for fibrin promotion of. alpha.-thrombin-catalyzed activation of plasma factor XIII | |
SUZUKI et al. | Protein S is essential for the activated protein C-catalyzed inactivation of platelet-associated factor Va | |
KR0127754B1 (en) | Composition of anticoagulants | |
Larrieu et al. | Comparative effects of fibrinogen degradation fragments D and E on coagulation | |
Chang et al. | Antithrombin reactions with. alpha.-and. gamma.-thrombins | |
IE58862B1 (en) | Blood coagulation inhibiting proteins, processes for preparing them and their uses | |
Griffith et al. | Characterization of the clotting activities of structurally different forms of activated factor IX. Enzymatic properties of normal human factor IXa alpha, factor IXa beta, and activated factor IX Chapel Hill. | |
Yin | Effect of heparin on the neutralization of factor Xa and thrombin by the plasma alpha-2-globulin inhibitor | |
Eisen et al. | Plasma kininogenases and their activators | |
US6068838A (en) | Purified multimerase | |
Salem et al. | The light chain of factor Va contains the activity of factor Va that accelerates protein C activation by thrombin. | |
Egberg | Coagulation studies in patients treated with Defibrase | |
DAVIE et al. | Molecular mechanisms in blood coagulation | |
Prydz | Studies on proconvertin (factor VII) V. Biosynthesis in suspension cultures of rat liver cells | |
Hemker et al. | Human Blood Coagulation: Biochemistry, Clinical Investigation and Therapy | |
Walker et al. | The molecular mechanisms of heparin action: III. The anticoagulant properties of polyanetholesulfonate | |
Walker | Interactions of protein S with membranes | |
Byrne et al. | The influence of metal ions in the activation of bovine factor IX by the coagulant protein of Russell's viper venom |